# Intravenous Immunoglobulin Therapy in Optic Neuritis

> **NCT00000117** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)**

## Conditions studied

- Optic Neuritis

## Interventions

- **DRUG:** Immunoglobulin

## Key facts

- **NCT ID:** NCT00000117
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-08
- **Primary completion:** —
- **Final completion:** 1997-12
- **Target enrollment:** — (—)
- **Last updated:** 2009-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000117, "Intravenous Immunoglobulin Therapy in Optic Neuritis". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00000117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*